FDA review of Pfizer data for child vaccinations could take weeks
SHREVEPORT, La. -- Pfizer continues to move toward authorization for its vaccine for children ages 5 to 11. The drug company has submitted the first round of data to the Food and D…
SHREVEPORT, La. -- Pfizer continues to move toward authorization for its vaccine for children ages 5 to 11. The drug company has submitted the first round of data to the Food and D…